Hostname: page-component-848d4c4894-sjtt6 Total loading time: 0 Render date: 2024-06-28T17:57:04.907Z Has data issue: false hasContentIssue false
  • English
  • Français

Identifying people at risk of dementia

Commentary on “The combination of olfactory dysfunction and depression increases the risk of incident dementia in older adults” by Kalam et al.

Published online by Cambridge University Press:  10 July 2023

Osvaldo P. Almeida Open the ORCID record for Osvaldo P. Almeida [Opens in a new window]
Osvaldo P. Almeida*
Affiliation:
Medical School, University of Western Australia, Perth, Australia
*
Email: osvaldo.almeida@uwa.edu.au
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Information
International Psychogeriatrics , Volume 36 , Special Issue 2: Issue Theme: Psycho-Bio-Social Risk Factors and Dementia , February 2024 , pp. 86 - 88
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of International Psychogeriatric Association

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Almeida, O. P., Hankey, G. J., Yeap, B. B., Golledge, J. and Flicker, L. (2017). Depression as a modifiable factor to decrease the risk of dementia. Translational Psychiatry, 7, e1117.CrossRefGoogle ScholarPubMed
Ashton, N. J. et al. (2023). Plasma and CSF biomarkers in a memory clinic: head-to-head comparison of phosphorylated tau immunoassays. Alzheimers & Dementia, 19, 1913–1924.CrossRefGoogle Scholar
Benussi, A. et al. (2021). Prodromal frontotemporal dementia: clinical features and predictors of progression. Alzheimers Research & Therapy, 13, 188.CrossRefGoogle ScholarPubMed
Birks, J. (2006). Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database of Systematic Reviews, 2006, CD005593.Google ScholarPubMed
Chan, J. Y. C., Yiu, K. K. L., Kwok, T. C. Y., Wong, S. Y. S. and Tsoi, K. K. F. (2019). Depression and antidepressants as potential risk factors in dementia: a systematic review and meta-analysis of 18 longitudinal studies. Journal of the American Medical Directors Association, 20, 279–286.CrossRefGoogle ScholarPubMed
Coughlin, D. G., Hurtig, H. I. and Irwin, D. J. (2020). Pathological influences on clinical heterogeneity in Lewy body diseases. Movement Disorders, 35, 5–19.CrossRefGoogle ScholarPubMed
Dobson, A. J., Flicker, L., Almeida, O. P., Waller, M. and Anstey, K. (2023). Different estimates of the prevalence of dementia in Australia, 2021. Medical Journal of Australia, 218, 320–321.CrossRefGoogle ScholarPubMed
Emberson, J. et al. (2014). Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. The Lancet, 384, 1929–1935.CrossRefGoogle ScholarPubMed
Farina, M. P., Zhang, Y. S., Kim, J. K., Hayward, M. D. and Crimmins, E. M. (2022). Trends in dementia prevalence, incidence, and mortality in the United States (2000–2016). Journal of Aging and Health, 34, 100–108.CrossRefGoogle ScholarPubMed
Goldberg, T. E., Choi, J., Lee, S., Gurland, B. and Devanand, D. P. (2021). Effects of restriction of activities and social isolation on risk of dementia in the community. International Psychogeriatrics, 33, 1207–1215.CrossRefGoogle ScholarPubMed
Hansson, O. et al. (2022). The Alzheimer’s Association appropriate use recommendations for blood biomarkers in Alzheimer’s disease. Alzheimers & Dementia, 18, 2669–2686.CrossRefGoogle ScholarPubMed
Hoevenaar-Blom, M. P. et al. (2021). Targeting vascular risk factors to reduce dementia incidence in old age: extended follow-up of the prevention of dementia by intensive vascular care (preDIVA) randomized clinical trial. JAMA Neurology, 78, 1527–1528.CrossRefGoogle ScholarPubMed
Kalam, S., Numbers, K., Lipnicki, D. M., Lam, B. P., Brodaty, H. and Reppermund, S. (2023). The combination of olfactory dysfunction and depression increases the risk of incident dementia in older adults. International Psychogeriatrics.Google ScholarPubMed
Krishna, M. et al. (2022). Size at birth, lifecourse factors, and cognitive function in late life: findings from the MYsore study of Natal effects on Ageing and Health (MYNAH) cohort in South India. International Psychogeriatrics, 34, 353–366.CrossRefGoogle Scholar
Liu, K. Y., Schneider, L. S. and Howard, R. (2021). The need to show minimum clinically important differences in Alzheimer’s disease trials. The Lancet Psychiatry, 8, 1013–1016.CrossRefGoogle ScholarPubMed
Livingston, G. et al. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet, 396, 413–446.CrossRefGoogle ScholarPubMed
McShane, R. et al. (2019). Memantine for dementia. Cochrane Database of Systematic Reviews, 3, CD003154.Google ScholarPubMed
Nichols, E. et al. (2022). Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease 2019. The Lancet Public Health, 7, E105–E125.CrossRefGoogle Scholar
Nogueira, R. G. et al. (2018). Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine, 378, 11–21.CrossRefGoogle ScholarPubMed
Roberts, R. O. et al. (2016). Association between olfactory dysfunction and amnestic mild cognitive impairment and Alzheimer disease dementia. JAMA Neurology, 73, 93–101.CrossRefGoogle ScholarPubMed
Scazufca, M., Almeida, O. P. and Menezes, P. R. (2010). The role of literacy, occupation and income in dementia prevention: the Sao Paulo Ageing & Health Study (SPAH). International Psychogeriatrics, 22, 1209–1215.CrossRefGoogle Scholar
Scazufca, M. et al. (2008). Risk factors across the life course and dementia in a Brazilian population: results from the Sao Paulo Ageing & Health Study (SPAH). Internatinal Journal of Epidemiology, 37, 879–890.CrossRefGoogle Scholar
van Charante, E. P. M. et al. (2016). Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. The Lancet, 388, 797–805.CrossRefGoogle Scholar
Walsh, S., Merrick, R., Richard, E., Nurock, S. and Brayne, C. (2022). Lecanemab for Alzheimer’s disease. British Medical Journal, 379, o3010.CrossRefGoogle ScholarPubMed
Wong, J., Motulsky, A., Eguale, T., Buckeridge, D. L., Abrahamowicz, M. and Tamblyn, R. (2016). Treatment indications for antidepressants prescribed in primary care in Quebec, Canada, 2006-2015. Journal of the American Medical Association, 315, 2230–2232.CrossRefGoogle ScholarPubMed
Xu, J. F., Zhang, Y. Q., Qiu, C. X. and Cheng, F. (2017). Global and regional economic costs of dementia: a systematic review. The Lancet, 390, S47.CrossRefGoogle Scholar